Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Adolescents and Adults With Chronic Plaque Psoriasis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Berk, MD
Arcutis Biotherapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arcutis Clinical Site 09
Rogers, Arkansas, United States
- Arcutis Clinical Site 11
Fountain Valley, California, United States
- Arcutis Clinical Site 07
Coral Gables, Florida, United States
- Arcutis Clinical Site 03
Doral, Florida, United States
- Arcutis Clinical Site 06
Hialeah, Florida, United States
- Arcutis Clinical Site 12
Miami, Florida, United States
- Arcutis Clinical Site 04
Sanford, Florida, United States
- Arcutis Clinical Site 02
Plainfield, Indiana, United States
- Arcutis Clinical Site 01
Dublin, Ohio, United States
- Arcutis Clinical Site 10
Arlington, Texas, United States
- Arcutis Clinical Site 05
San Antonio, Texas, United States
- Arcutis Clinical Site 08
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Mar 2020
- Primary completion
- 25 Mar 2021
- Completion
- 25 Mar 2021
- Last update posted
- 3 Aug 2022
- Registered enrollment
- 26
- Registry id
- NCT04279119
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.